Medical Update and Outlook
Transition to
Stability
Recovery in R&D
Click on each section to watch the presentation, download slides, or view additional content
Dr. Jeffrey Spaeder, M.D.
Chief Scientific and Medical Officer, IQVIA
NEXT
An assessment of the virus, its physical impact, and the complex requirements for ending the pandemic.
WATCH
RESOURCES
WATCH
PREVIOUS
NEXT
PREVIOUS
DownloaD
RESOURCES
HOME
A Catalyst for Change
WATCH FULL presentation
DOWNLOAD PDF
Contact us
Title
DOWNLOAD SLIDES
Data call out of key messages
Slide carousel, page 3
DOWNLOAD SLIDES
DOWNLOAD SLIDES
DOWNLOAD SLIDES
WATCH
RESOURCES
DOWNLOAD SLIDES
PREVIOUS
RESOURCES
Data call out of key messages
Slide carousel, page 3
DOWNLOAD SLIDES
NEXT
PREVIOUS
WATCH
NEXT
WATCH
RESOURCES
DOWNLOAD SLIDES
PREVIOUS
RESOURCES
Data call out of key messages
Slide carousel, page 2
Data call out of key messages
Slide carousel, page 3
DOWNLOAD SLIDES
NEXT
PREVIOUS
DOWNLOAD
WATCH
NEXT
Title
Murray Aitken
SVP, IQVIA and Executive Director, IQVIA Institute for Human Data Science
Title
Costa Panagos
President, R&D Operations, IQVIA
In order to move as quickly as possible to
the end, it is so important that we leverage existing knowledge and be constantly open
to new information.”
An update on the spread of COVID-19, the trajectory of active cases, and a quantitative analysis to help assess "reopening" around the world.
A look at how clinical trial operations are moving from immediate response to long term recovery, and the momentum driving innovative medicines forward.
Q2 Solutions Webinar: Laboratory Support for COVID-19 Clinical Trials
Webinar: Impact of COVID-19 on InVitro Diagnostics
Placeholder
Lorem ipsum dolor
DOWNLOAD SLIDES
WATCH
WATCH
Transition to
Stability
Recovery in R&D
A Catalyst for Change
Transition to
Stability
Recovery in R&D
A Catalyst for Change
IQVIA Active Cases Curve Simulator
DOWNLOAD
Report: The Impact of COVID-19 on Europe's pharma market
READ
Webinar: The Impact of COVID-19 on US Health Systems
WATCH
Webinar: Clinical Trial Continuity
WATCH
Webinar: The impact of COVID-19 on Cell and Gene Therapy
WATCH
Webinar: Adopting Virtual Approaches in Onoclogy Trials link
WATCH
WATCH
RESOURCES
DOWNLOAD SLIDES
PREVIOUS
RESOURCES
Article: Biopharma joins forces to fight COVID-19
READ
Webinar: Accelerating changes in customer interactions
WATCH
Article: COVID-19 as a positive turning point
READ
It is worthwhile to consider what changes we have had to make, are changes that we should be making.”
DOWNLOAD SLIDES
NEXT
PREVIOUS
DOWNLOAD
Alistair Grenfell
President, Europe, Middle East, Africa and South Asia, IQVIA
Marla Kessler
SVP, Strategy Marketing and Communications, IQVIA
WATCH
NEXT
A Catalyst for Change
Drivers of change and long-term implications for life sciences, and a look at COVID-19 as a catalyst for building a stronger, more resilient healthcare ecosystem.
Murray Aitken
SVP, IQVIA and Executive Director, IQVIA Institute for Human Data Science
Recovery in R&D
An introduction from Murray Aitken, SVP at IQVIA and Executive Director of the IQVIA Institute for Human Data Science.
DOWNLOAD
DOWNLOAD
DOWNLOAD
DOWNLOAD
Transition to Stability
DOWNLOAD
This index provides an objective, evidence-based way to assess readiness to reopen and resume health services.”
Medical Update and Outlook
We are committed to driving science and research forward for patients around the world."
Medical Update and Outlook
Medical Update and Outlook